Open access
Open access
Powered by Google Translator Translator

TB/Non-TB Mycobacterial Infections

M-A | Exposure to smoke, overcrowding, poor living conditions, and contact with TB cases identified as risk conditions for pediatric TB

24 Jul, 2023 | 12:43h | UTC

Risk factors for the development of tuberculosis among the pediatric population: a systematic review and meta-analysis – European Journal of Pediatrics

 


M-A | Risk factors for non-tuberculous mycobacterial pulmonary disease

27 Jun, 2023 | 13:27h | UTC

Risk Factors for Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) A systematic literature review and meta-analysis – Chest

Commentary: Comorbid respiratory disease key predictor of NTM-PD – MDedge

 


M-A | CRP at 5 mg/L cut-off efficient for tuberculosis screening in HIV outpatients

21 Jun, 2023 | 13:30h | UTC

Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis – European Respiratory Review

 

Commentary on Twitter

 


M-A | Residual respiratory disability after successful treatment of pulmonary tuberculosis

2 Jun, 2023 | 12:20h | UTC

Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis – eClinicalMedicine

 


USPSTF Statement | Asymptomatic adults at increased risk should be screened for latent TB

5 May, 2023 | 15:34h | UTC

Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement – JAMA

Evidence Report: Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Editorials:

Screening for Latent Tuberculosis Infection Among Non–US-Born Adults in the US: A Path Toward Elimination – JAMA

Screening for Latent Tuberculosis Infection – JAMA Network Open

JAMA Patient Page: Screening for Latent Tuberculosis

Author Interview: USPSTF Recommendation: Screening for Latent Tuberculosis Infection in Adults

 


Brief Review | Management of latent tuberculosis infection

5 May, 2023 | 15:32h | UTC

Management of Latent Tuberculosis Infection – JAMA (free for a limited period)

 


Review | Transforming tuberculosis diagnosis

5 May, 2023 | 15:18h | UTC

Transforming tuberculosis diagnosis – Nature Microbiology (if the link is paywalled, try this one)

 

Commentary on Twitter

 


Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people

26 Apr, 2023 | 14:11h | UTC

Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people – European Respiratory Review

 


WHO releases first-ever Standard on universal access to rapid TB diagnostics

24 Apr, 2023 | 14:04h | UTC

News Release: WHO releases first-ever Standard on universal access to rapid TB diagnostics – World Health Organization

WHO Standard: Universal access to rapid tuberculosis diagnostics – World Health Organization

 


Improving cascade outcomes for active TB | A global systematic review and meta-analysis of TB interventions

30 Mar, 2023 | 14:17h | UTC

Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions – PLOS Medicine

 


M-A | The natural history of untreated pulmonary tuberculosis in adults

28 Mar, 2023 | 14:42h | UTC

The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis – The Lancet Respiratory Medicine (free registration required)

 

Commentary from the author on Twitter

 


SR | Post-tuberculosis sequelae in children and adolescents

27 Mar, 2023 | 13:16h | UTC

Post-tuberculosis sequelae in children and adolescents: a systematic review – The Lancet Infectious Diseases (free registration required)

 


M-A | Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine

27 Mar, 2023 | 13:14h | UTC

Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis – The Lancet Respiratory Medicine (free registration required)

Invited Commentary: Shorter regimens for tuberculosis preventive treatment: piecing together the global implementation jigsaw – The Lancet Respiratory Medicine (free registration required)

 

Commentary on Twitter

 


M-A | Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis

23 Mar, 2023 | 12:50h | UTC

Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis – The Lancet Child & Adolescent Health

News Release: New Algorithms Could Improve Pediatric Tuberculosis Diagnosis – Yale School of Public Health

 

Commentary from the author on Twitter (thread – click for more)

 


Review | Evidence-based approach to diagnosis and management of abdominal tuberculosis

16 Mar, 2023 | 13:17h | UTC

Evidence-based approach to diagnosis and management of abdominal tuberculosis – Indian Journal of Gastroenterology (if the link is paywalled, try this one)

 

Commentary from the author on Twitter

 


RCT | An initial 8-week bedaquiline-linezolid regimen shows promise for the treatment of rifampin-susceptible tuberculosis

22 Feb, 2023 | 12:50h | UTC

Summary: This randomized trial compared a standard 6-month rifampin-based tuberculosis treatment to a strategy that involved shorter initial treatment with extended therapy for persistent disease, monitoring, and retreatment for relapse. The results showed that the strategy involving an 8-week bedaquiline-linezolid regimen was noninferior to standard treatment for clinical outcomes. The experimental strategy was associated with a shorter total duration of treatment with no evident safety concerns.

Article: Treatment Strategy for Rifampin-Susceptible Tuberculosis – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Shorter drug regimen shows promise in TB trial – CIDRAP

 


Review | Contemporary pharmacotherapies for nontuberculosis mycobacterial infections

17 Feb, 2023 | 13:03h | UTC

Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review – Infectious Diseases and Therapy

 


Review | Female genital tuberculosis

16 Feb, 2023 | 14:42h | UTC

Female Genital Tuberculosis – Open Forum Infectious Diseases

 


M-A | Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection

24 Jan, 2023 | 14:25h | UTC

Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection: a systematic review and meta-analysis – Clinical Infectious Diseases

 

Commentary on Twitter

 


Brief review and algorithm | Management of latent tuberculosis infection

23 Jan, 2023 | 13:35h | UTC

Management of Latent Tuberculosis Infection – JAMA (free for a limited period)

 


Consensus statement | Use of a 4-month treatment regimen for drug susceptible TB in children with uncomplicated disease

18 Jan, 2023 | 14:25h | UTC

Consensus statement on the use of a four-month treatment regimen for drug susceptible tuberculosis in children (< 10 years of age) with uncomplicated disease – Australian Government Department of Health and Aged Care

 


RCT | A 24-week, all-oral regimen for rifampin-resistant tuberculosis

12 Jan, 2023 | 13:27h | UTC

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis – New England Journal of Medicine

Commentary: Trial results show superiority of shorter, all-oral treatment for drug-resistant TB – CIDRAP

 


WHO consolidated guidelines on tuberculosis | Drug-resistant tuberculosis treatment, 2022 update

12 Jan, 2023 | 13:30h | UTC

WHO consolidated guidelines on tuberculosis. Module 4: treatment – drug-resistant tuberculosis treatment, 2022 update – World Health Organization

See also:

WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment

WHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease

WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 2021 update

WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents

 


Collection of Cochrane evidence on diagnosing tuberculosis.

1 Dec, 2022 | 13:56h | UTC

Collection of Cochrane evidence on diagnosing tuberculosis – Cochrane Library

 


WHO Global tuberculosis report 2022.

29 Nov, 2022 | 14:25h | UTC

Global tuberculosis report 2022 – World Health Organization

News Release: Tuberculosis deaths and disease increase during the COVID-19 pandemic – World Health Organization

Video Summary: WHO Global Tuberculosis Report 2022: Key findings and messages – World Health Organization

 

Commentary on Twitter (thread – click for more)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.